---
figid: PMC7696189__ijms-21-08620-g007
figtitle: Tyrosine kinase inhibitor (TKI)-based OFF-switch
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7696189
filename: ijms-21-08620-g007.jpg
figlink: pmc/articles/PMC7696189/figure/ijms-21-08620-f007/
number: F7
caption: Schematic representation of the tyrosine kinase inhibitor (TKI)-based OFF-switch.
  The TKI dasatinib inhibits the phosphorylation of CD3ζ and ZAP70, which have a key
  role in the T-cell receptor (TCR) signaling pathway (Adapted from Wu et al., 2019).
papertitle: Engineering Next-Generation CAR-T Cells for Better Toxicity Management.
reftext: Alain E. Andrea, et al. Int J Mol Sci. 2020 Nov;21(22):8620.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9195689
figid_alias: PMC7696189__F7
figtype: Figure
redirect_from: /figures/PMC7696189__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7696189__ijms-21-08620-g007.html
  '@type': Dataset
  description: Schematic representation of the tyrosine kinase inhibitor (TKI)-based
    OFF-switch. The TKI dasatinib inhibits the phosphorylation of CD3ζ and ZAP70,
    which have a key role in the T-cell receptor (TCR) signaling pathway (Adapted
    from Wu et al., 2019).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD19
  - CASR
  - CXADR
  - PRKAR1A
  - SPG7
  - NR1I3
  - TRIM13
  - CXADRP1
  - CD4
  - CD8A
  - CD8B
  - LCK
  - ZAP70
---
